Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, 15771 Athens, Greece.
Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland.
Biomolecules. 2021 Feb 13;11(2):275. doi: 10.3390/biom11020275.
Prostaglandin E (PGE) is a key mediator of inflammation, and consequently huge efforts have been devoted to the development of novel agents able to regulate its formation. In this work, we present the synthesis of various α-ketoheterocycles and a study of their ability to inhibit the formation of PGE at a cellular level. A series of α-ketobenzothiazoles, α-ketobenzoxazoles, α-ketobenzimidazoles, and α-keto-1,2,4-oxadiazoles were synthesized and chemically characterized. Evaluation of their ability to suppress the generation of PGE in interleukin-1β plus forskolin-stimulated mesangial cells led to the identification of one α-ketobenzothiazole (GK181) and one α-ketobenzoxazole (GK491), which are able to suppress the PGE generation at a nanomolar level.
前列腺素 E (PGE) 是炎症的关键介质,因此人们投入了大量精力来开发能够调节其形成的新型药物。在这项工作中,我们展示了各种α-酮杂环的合成及其在细胞水平上抑制 PGE 形成的能力。合成了一系列α-酮苯并噻唑、α-酮苯并恶唑、α-酮苯并咪唑和α-酮-1,2,4-噁二唑,并对其进行了化学表征。评估它们抑制白细胞介素-1β加 forskolin 刺激的肾小球系膜细胞中 PGE 生成的能力,导致鉴定出一种α-酮苯并噻唑(GK181)和一种α-酮苯并恶唑(GK491),它们能够在纳摩尔水平抑制 PGE 的生成。